Meeting in regard to Acomplia set for June 2007 - FDA Panel
The next meeting of the endocrinologic and metabolic drugs advisory has been scheduled for June 13th. This is considered bad news for Sanofi - Aventis. Read More...

Acomplia and Surgery Should be a last Option says UK Panel
A panel in the U.K government which assesses the cost effectiveness of various medical therapies states that diet drugs like Acomplia (rimonbant) or surgery should be the last option available to treat obesity.Read More...

FDA Ignores Sanofi's Acomplia
Acomplia is now expected before April end next year. There is likely to be a six month review period because of FDA's decision. Read More...

Diet Drug Acomplia has been Referred to As 'Magic Pill' by Cbs Report
The most exciting thing is not only that it induces weight loss, but over and above the effect induced by weight loss, you get more effect on the cholesterol, on the sugar, on the other risk factors that make obesity such a risky Read More...

New Drug Helps Weight loss and Blood Sugar
The new drug in the market by the name of rimonabant, helps promote weight loss and improve blood sugar control in individuals with type 2 diabetes. The maker of rimonabant( brand name Acomplia) is Sanofi-Aventis. Read More...